Guo Zhiru, Draheim Kyle, Lyle Stephen
Department of Cancer Biology, University of Massachusetts Medical School, MA, USA.
J Vis Exp. 2011 Mar 31(49):2561. doi: 10.3791/2561.
The homeostasis of all self-renewing tissues is dependent on adult stem cells. As undifferentiated stem cells undergo asymmetric divisions, they generate daughter cells that retain the stem cell phenotype and transit-amplifying cells (TA cells) that migrate from the stem cell niche, undergo rapid proliferation and terminally differentiate to repopulate the tissue. Epithelial stem cells have been identified in the epidermis, hair follicle, and intestine as cells with a high in vitro proliferative potential and as slow-cycling label-retaining cells in vivo (1-3). Adult, tissue-specific stem cells are responsible for the regeneration of the tissues in which they reside during normal physiologic turnover as well as during times of stress (4-5). Moreover, stem cells are generally considered to be multi-potent, possessing the capacity to give rise to multiple cell types within the tissue (6). For example, rodent hair follicle stem cells can generate epidermis, sebaceous glands, and hair follicles (7-9). We have shown that stem cells from the human hair follicle bulge region exhibit multi-potentiality (10). Stem cells have become a valuable tool in biomedical research, due to their utility as an in vitro system for studying developmental biology, differentiation, tumorigenesis and for their possible therapeutic utility. It is likely that adult epithelial stem cells will be useful in the treatment of diseases such as ectodermal dysplasias, monilethrix, Netherton syndrome, Menkes disease, hereditary epidermolysis bullosa and alopecias (11-13). Additionally, other skin problems such as burn wounds, chronic wounds and ulcers will benefit from stem cell related therapies (14,15). Given the potential for reprogramming of adult cells into a pluripotent state (iPS cells)(16,17), the readily accessible and expandable adult stem cells in human skin may provide a valuable source of cells for induction and downstream therapy for a wide range of disease including diabetes and Parkinson's disease.
所有自我更新组织的稳态都依赖于成体干细胞。未分化的干细胞进行不对称分裂时,会产生保留干细胞表型的子代细胞以及从干细胞生态位迁移出来的过渡放大细胞(TA细胞),TA细胞会快速增殖并终末分化以补充组织。上皮干细胞已在表皮、毛囊和肠道中被鉴定出来,它们在体外具有高增殖潜能,在体内是慢周期标记保留细胞(1-3)。成体、组织特异性干细胞负责在正常生理更新以及应激期间其所在组织的再生(4-5)。此外,干细胞通常被认为是多能的,具有在组织内产生多种细胞类型的能力(6)。例如,啮齿动物毛囊干细胞可以产生表皮、皮脂腺和毛囊(7-9)。我们已经表明,来自人毛囊隆突区的干细胞具有多能性(10)。由于干细胞作为研究发育生物学、分化、肿瘤发生的体外系统的效用以及其可能的治疗效用,它们已成为生物医学研究中的一种有价值的工具。成体上皮干细胞很可能在治疗诸如外胚层发育不良、单毛症、 Netherton综合征、门克斯病、遗传性大疱性表皮松解症和脱发等疾病中发挥作用(11-13)。此外,其他皮肤问题,如烧伤创面、慢性伤口和溃疡,也将从干细胞相关治疗中受益(14,15)。鉴于成体细胞重编程为多能状态(诱导多能干细胞)的可能性(16,17),人皮肤中易于获取和扩增的成体干细胞可能为包括糖尿病和帕金森病在内的多种疾病的诱导和下游治疗提供有价值的细胞来源。